Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Immunothérapie - Vaccinothérapie
Extract
KEYNOTE-086 : A Phase II Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC).